✨ Your Portfolio is fetched and updated from zerodha.
Nano
Market Cap
₹329 Cr.
P/E
7.74

Key Ratios

Market cap
Market cap
329 Cr
PE
PE
7.74
Prom Holding
Prom Holding
-
ROE (%)
ROE (%)
5.99
ROCE (%)
ROCE (%)
7.67
Div Yield (%)
Div Yield (%)
1.07
Sales
Sales
404 Cr
OPM (%)
OPM (%)
12.74 %
Debt to Equity
Debt to Equity
-
About
Nath Bio-Genes is in the Miscellaneous sector with a M.cap of 329.00 Cr and a PE ratio… Read more
Low
52W Range
High

Insufficient data

Timeline

Dividend Update Board Meeting Financials

Key company specific updates

Custom financial statementNew
Edit rows
Forensics

0 Yes

Positive for this company

0 Neutral

Neutral for this company

0 No

Negative for this company

0 No Data

Insufficient data to analyse

Peer Comparison
FAQs on Nath Bio-Genes (India) Ltd. Business

Nath Bio-Genes is a leading seed company in India with a focus on research and development. They offer a wide range of products in major field crops, vegetables, and bio-stimulants, and have received ISO 9001 certification.

Nath Bio-Genes major competitors are JK Agri Genetics, Shree Oswal Seeds, Shree Ganesh BioTech, Bombay Super Hybrid, Kaveri Seed, Riddhi Siddhi Gluco, ABans Enterprises.
Market Cap of Nath Bio-Genes is ₹329 Crs.
While the median market cap of its peers are ₹226 Crs.

Nath Bio-Genes seems to be less financially stable compared to its competitors.
Altman Z score of Nath Bio-Genes is 2.24 and is ranked 6 out of its 8 competitors.

Company Filing
Discussions & Analysis
Ideas Dashboard
Results
Timeline
Watchlist
Portfolio
Alerts
Stock Screener
Market
Raw Material